Agilent Technologies Inc (NYSE:A) Shares Purchased by Riverhead Capital Management LLC
Riverhead Capital Management LLC raised its position in Agilent Technologies Inc (NYSE:A) by 7.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,775 shares of the medical research company’s stock after buying an additional 750 shares during the period. Riverhead Capital Management LLC’s holdings in Agilent Technologies were worth $805,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of the business. Findlay Park Partners LLP raised its holdings in Agilent Technologies by 51.9% in the second quarter. Findlay Park Partners LLP now owns 4,500,000 shares of the medical research company’s stock valued at $336,015,000 after acquiring an additional 1,538,234 shares in the last quarter. American Century Companies Inc. raised its stake in shares of Agilent Technologies by 20.6% in the 1st quarter. American Century Companies Inc. now owns 4,928,415 shares of the medical research company’s stock valued at $396,146,000 after purchasing an additional 840,850 shares in the last quarter. Investec Asset Management LTD raised its stake in shares of Agilent Technologies by 447.2% in the 2nd quarter. Investec Asset Management LTD now owns 648,507 shares of the medical research company’s stock valued at $14,350,000 after purchasing an additional 529,993 shares in the last quarter. Cantillon Capital Management LLC lifted its position in shares of Agilent Technologies by 11.5% during the second quarter. Cantillon Capital Management LLC now owns 3,945,223 shares of the medical research company’s stock worth $294,589,000 after purchasing an additional 405,598 shares during the last quarter. Finally, MERIAN GLOBAL INVESTORS UK Ltd lifted its position in shares of Agilent Technologies by 6,833.0% during the first quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 379,583 shares of the medical research company’s stock worth $30,510,000 after purchasing an additional 374,108 shares during the last quarter.
Shares of Agilent Technologies stock traded up $1.84 on Wednesday, reaching $76.61. 100,947 shares of the company were exchanged, compared to its average volume of 2,508,173. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.72 and a current ratio of 2.13. The company’s 50-day moving average is $70.14 and its two-hundred day moving average is $73.98. The firm has a market cap of $22.96 billion, a price-to-earnings ratio of 27.52, a P/E/G ratio of 2.05 and a beta of 1.40. Agilent Technologies Inc has a 1-year low of $61.01 and a 1-year high of $82.27.
A has been the subject of several research analyst reports. Robert W. Baird reissued an “outperform” rating and issued a $82.00 price objective (up from $79.00) on shares of Agilent Technologies in a report on Thursday, August 15th. ValuEngine downgraded Agilent Technologies from a “buy” rating to a “hold” rating in a report on Friday, July 12th. Wolfe Research began coverage on Agilent Technologies in a research report on Thursday, May 30th. They issued a “peer perform” rating for the company. Barclays downgraded Agilent Technologies from an “overweight” rating to an “equal weight” rating and lowered their price target for the company from $86.00 to $78.00 in a report on Monday, July 15th. Finally, Deutsche Bank dropped their price target on Agilent Technologies from $90.00 to $85.00 and set a “buy” rating on the stock in a research report on Wednesday, May 15th. Six analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $84.77.
In other Agilent Technologies news, Director Heidi Fields sold 4,000 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $70.96, for a total value of $283,840.00. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Read More: What is a Roth IRA?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.